← Back to Search

Dietary Supplement

Moringa Supplementation for Breastfeeding

N/A
Recruiting
Led By Suzanna Attia, MD
Research Sponsored by University of Kentucky
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Infant is 2-6 weeks old and a singleton birth
Aged 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

Study Summary

This trial is testing whether taking moringa leaves can help improve milk quality and quantity, as well as the health of the infants.

Who is the study for?
This trial is for breastfeeding moms aged 18 or older with infants born between 32-36 weeks who are willing to breastfeed/pump for four weeks and participate in study activities. Excluded are those using certain medications, with a history of breast surgery or conditions, drug use during pregnancy, or whose infants have specific health issues.Check my eligibility
What is being tested?
The trial tests if taking Moringa oleifera leaf powder (4g daily) improves the quantity and quality of breastmilk compared to a placebo over four weeks. The hypothesis suggests that moringa will increase milk production and benefit infant health.See study design
What are the potential side effects?
Potential side effects aren't specified here but generally could include digestive discomfort due to new supplementation. Participants should report any unexpected symptoms they experience during the trial.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My baby is between 2-6 weeks old and was not part of a multiple birth.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Milk output
Secondary outcome measures
% mother's own milk consumed by infant
Other outcome measures
Maternal milk vitamin A

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MoringaExperimental Treatment1 Intervention
4 g moringa leaf powder in green capsules divided into 4 capsules twice daily x 7 days
Group II: ControlPlacebo Group1 Intervention
comparable weight green capsules with cornstarch divided into 4 capsules twice daily x 7 days

Find a Location

Who is running the clinical trial?

University of KentuckyLead Sponsor
185 Previous Clinical Trials
226,582 Total Patients Enrolled
University of IdahoOTHER
19 Previous Clinical Trials
2,664 Total Patients Enrolled
Suzanna Attia, MDPrincipal InvestigatorUniversity of Kentucky

Media Library

Moringa leaf powder (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05333939 — N/A
Breastfeeding Research Study Groups: Moringa, Control
Breastfeeding Clinical Trial 2023: Moringa leaf powder Highlights & Side Effects. Trial Name: NCT05333939 — N/A
Moringa leaf powder (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05333939 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings to join this research endeavor?

"From clinicaltrials.gov we can ascertain that this medical trial is presently looking for participants; the original posting was on May 17th 2022 and there have been recent updates made to it, with edits occurring as recently as June 28th 2022."

Answered by AI

How many participants has this investigational research enrolled?

"Indeed, according to clinicaltrials.gov, this trial is actively recruiting as of June 28th 2022 with an initial posting date of May 17th 2022. At present, 60 participants are needed from just one medical site."

Answered by AI
~0 spots leftby Apr 2024